Abstract Summary Pharmacological enhancement of endoplasmic reticulum (ER) proteostasis is an attractive strategy to mitigate pathology linked to etiologically-diverse protein misfolding diseases.

A bottleneck in ensuring access to widespread molecular diagnostics, especially in low- and middle-income countries, has been ...